Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05029154 · ClinicalTrials.gov registry record · NA
Exercise Preconditioning in Ovarian Cancer
A NA study, sponsored by University of Virginia.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05029154: Clinical Trial NA study, sponsored by University of Virginia.
NCT05029154 is a NA study that was terminated before completion, run by University of Virginia. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05029154, a NA study, was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if exercise preconditioning can mitigate the off target effects of chemotherapy treatment on measures of cardiovascular function, peripheral neuropathy, and quality of life.
Primary Outcome
Change in VO2peak (L/min) measured at pre-surgery, pre-chemotherapy, and post chemotherapy
Interventions
- BEHAVIORAL Attention control
- BEHAVIORAL High intensity interval exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-10-21 |
| Est. Completion | 2025-06-04 |
| Phase | NA |
Why NCT05029154 stopped before completion
NCT05029154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.
NCT05029154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05029154 about?
NCT05029154 is a clinical study titled "Exercise Preconditioning in Ovarian Cancer". The purpose of this study is to determine if exercise preconditioning can mitigate the off target effects of chemotherapy treatment on measures of cardiovascular function, peripheral neuropathy, and quality of life.
What is the current status of trial NCT05029154?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2021-10-21. Estimated completion is 2025-06-04.
What interventions are being tested in trial NCT05029154?
The interventions under investigation include: Attention control (BEHAVIORAL), High intensity interval exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05029154?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05029154's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI